April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization
Author Affiliations & Notes
  • N. Matsumura
    Ophthalmology, Osaka University Medical School, Suita, Japan
  • M. Tsujikawa
    Ophthalmology, Osaka University Medical School, Suita, Japan
  • P. Xie
    Ophthalmology, Osaka University Medical School, Suita, Japan
  • K. Nakai
    Ophthalmology, Osaka University Medical School, Suita, Japan
  • Y. Saishin
    Ophthalmology, Toho University Sakura Hospital, Chiba, Japan
  • M. Suzuki
    Ophthalmology, Osaka University Medical School, Suita, Japan
  • H. Sakaguchi
    Ophthalmology, Osaka University Medical School, Suita, Japan
  • M. Kamei
    Ophthalmology, Osaka University Medical School, Suita, Japan
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3360. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Matsumura, M. Tsujikawa, P. Xie, K. Nakai, Y. Saishin, M. Suzuki, H. Sakaguchi, M. Kamei; Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3360.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Humans are constantly exposed to low levels of lipopolysaccharide (LPS) through infection. Recent studies demonstrate that infections, like Chlamydia pneumonia, may be a risk factor for age-related macular degeneration. The purpose of this study is to evaluate whether LPS can modulate the development of choroidal neovascularization (CNV).

Methods: : CNV was induced by laser photocoagulation in 8- to 10-week-old male C57BL/6 mice. Mice were given an intraperitoneal injection of 20µg LPS at 1, 2, 3 and 4 days before the laser treatment. As a control, PBS was administrated intraperitoneally. Serum levels of IL-10 were measured by ELISA over time. At 10 days after photocoagulation, mice were perfused with fluorescein-labeled dextran and euthanized. RPE-choroid-sclera flat mounts were prepared and the area of CNV was quantified with digital analysis software. As a second experiment, we intravitreally injected an anti-IL-10 antibody immediately after laser treatment in the mice with LPS pretreatment, and evaluated the CNV area.

Results: : The areas of CNV in the mice with LPS pretreatment at 1, 2, 3 and 4 days before photocoagulation were 16241, 14781, 15876, and 16606 µm2, respectively, which were significantly smaller than that of the control mice (21350µm2; p=0.047, 0.006, 0.028 and 0.057, respectively). The LPS CNV inhibitory effect was largest in the mice given LPS pretreatment 2 days before photocoagulation. After LPS pretreatment, serum IL-10 concentration increased (before, 1 and 2 days after treatment; 9.8, 207.8 and 92.8 pg/ml, respectively). Intravitreal injection of anti-IL-10 antibody inhibits CNV suppression by LPS pretreatment (p=0.0014).

Conclusions: : CNV formation was suppressed by LPS pretreatment, presumably via IL-10 secretion. Our data suggested that increased IL-10 might be responsible for the CNV reduction. Low levels of LPS through infection can suppress the development of CNV.

Keywords: choroid: neovascularization • age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×